Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A case of radiation recall pneumonitis induced by erlotinib, which can be related to high plasma concentration.

× No keyword cloud information.

11 in total

1. Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer.

Authors: Haitam Nasrallah; Gil Bar-Sela; Nissim Haim
Journal: Med Oncol Date: 2011-01-25 Impact factor: 3.064

2. Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer.

Authors: Xiao Ding; Wei Ji; Junling Li; Xiangru Zhang; Luhua Wang
Journal: Radiat Oncol Date: 2011-03-06 Impact factor: 3.481

Review 3. Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas.

Authors: Rashmi R Shah
Journal: Drug Saf Date: 2016-11 Impact factor: 5.606

Review 4. Radiation-Induced Lung Injury: Assessment and Management.

Authors: Alexander N Hanania; Walker Mainwaring; Yohannes T Ghebre; Nicola A Hanania; Michelle Ludwig
Journal: Chest Date: 2019-04-15 Impact factor: 9.410

5. Population pharmacokinetics/pharmacodynamics of erlotinib and pharmacogenomic analysis of plasma and cerebrospinal fluid drug concentrations in Japanese patients with non-small cell lung cancer.

Authors: Masahide Fukudo; Yasuaki Ikemi; Yosuke Togashi; Katsuhiro Masago; Young Hak Kim; Tadashi Mio; Tomohiro Terada; Satoshi Teramukai; Michiaki Mishima; Ken-Ichi Inui; Toshiya Katsura
Journal: Clin Pharmacokinet Date: 2013-07 Impact factor: 6.447

6. Predicting treatment related imaging changes (TRICs) after radiosurgery for brain metastases using treatment dose and conformality metrics.

Authors: B Frazier Taylor; Jonathan P Knisely; Jack M Qian; James B Yu; Veronica L Chiang
Journal: J Radiosurg SBRT Date: 2016

7. Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy.

Authors: Hongqing Zhuang; Hailing Hou; Zhiyong Yuan; Jun Wang; Qingsong Pang; Lujun Zhao; Ping Wang
Journal: Onco Targets Ther Date: 2014-05-24 Impact factor: 4.147

Review 8. The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients.

Authors: Xiaoyang Zhai; Jian Zhang; Yaru Tian; Ji Li; Wang Jing; Hongbo Guo; Hui Zhu
Journal: Cancer Biol Med Date: 2020-08-15 Impact factor: 4.248

Review 9. The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review.

Authors: Alistair R Miller; Renee Manser
Journal: Transl Lung Cancer Res Date: 2021-06

10. Radiation Recall Pneumonitis Induced by Anti-PD-1 Blockade: A Case Report and Review of the Literature.

Authors: Yu Chen; Zhaoqin Huang; Ligang Xing; Xiangjiao Meng; Jinming Yu
Journal: Front Oncol Date: 2020-04-28 Impact factor: 6.244